| P50 | author | Matthias Guckenberger | Q40544777 |
| | Nicolaus Andratschke | Q85835192 |
| | Alexander Rühle | Q87149318 |
| P2093 | author name string | Shankar Siva | |
| P2860 | cites work | [German S3 guideline for renal cell carcinoma : Presentation and discussion of essential aspects for the radiation oncologist] | Q88803135 |
| | Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK | Q91450077 |
| | Epidemiology of Renal Cell Carcinoma | Q91652784 |
| | Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† | Q91784083 |
| | The Cyberknife: a frameless robotic system for radiosurgery | Q28280076 |
| | Renal cell carcinoma | Q30235364 |
| | Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis | Q30437879 |
| | Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials | Q30656342 |
| | Gamma knife radiosurgery for renal cell carcinoma brain metastases | Q31123227 |
| | Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials | Q33530019 |
| | Novel application of stereotactic ablative radiotherapy using CyberKnife(®) for early-stage renal cell carcinoma in patients with pre-existing chronic kidney disease: Initial clinical experiences | Q33778271 |
| | Stereotactic body radiation therapy for inoperable early stage lung cancer | Q34010065 |
| | Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials | Q34185852 |
| | Systematic review of oncological outcomes following surgical management of localised renal cancer | Q34190464 |
| | The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth | Q34610047 |
| | Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery | Q34610661 |
| | Kidney tumor location measurement using the C index method | Q34617938 |
| | Effect of different breathing patterns in the same patient on stereotactic ablative body radiotherapy dosimetry for primary renal cell carcinoma: a case study | Q34666936 |
| | Preoperative Irradiation in the Treatment of Renal Adenocarcinoma | Q34706528 |
| | A review of human cell radiosensitivity in vitro | Q34740068 |
| | A review of kidney motion under free, deep and forced-shallow breathing conditions: implications for stereotactic ablative body radiotherapy treatment. | Q35064379 |
| | Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control | Q35068844 |
| | The use of dual vacuum stabilization device to reduce kidney motion for stereotactic radiotherapy planning | Q35087413 |
| | SBRT in operable early stage lung cancer patients. | Q35200592 |
| | Radiation and ceramide-induced apoptosis | Q35208833 |
| | Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity | Q35466044 |
| | Dosimetric comparison of carbon ion radiotherapy and stereotactic body radiotherapy with photon beams for the treatment of hepatocellular carcinoma | Q36071172 |
| | Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT). | Q36222951 |
| | Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy | Q36846412 |
| | Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial | Q36932216 |
| | Renal cell carcinoma in young and old patients--is there a difference? | Q37040648 |
| | Extracorporeal high intensity focused ultrasound for renal tumours: a 3-year follow-up | Q37709465 |
| | The role of radiologic imaging and biopsy in renal tumor ablation | Q37737120 |
| | Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis | Q38010568 |
| | A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma | Q38056219 |
| | CyberKnife for inoperable renal tumors: Canadian pioneering experience | Q38152870 |
| | Radiotherapy for renal-cell carcinoma | Q38201568 |
| | Thermal ablation in renal cell carcinoma management: a comprehensive review | Q38232672 |
| | Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC). | Q38394502 |
| | Radiofrequency ablation versus partial nephrectomy for treatment of renal masses: A systematic review and meta-analysis | Q38680895 |
| | Consensus statement from the International Radiosurgery Oncology Consortium for Kidney for primary renal cell carcinoma | Q38720384 |
| | Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology | Q38735408 |
| | Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy | Q38975732 |
| | Microwave ablation of renal tumors: A narrative review of technical considerations and clinical results | Q39051974 |
| | Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience | Q39173284 |
| | Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis. | Q39292197 |
| | Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma | Q39476399 |
| | Spontaneous regression of metastases of renal cancer: A report of two cases including the first recorded regression following irradiation of a dominant metastasis and review of the world literature | Q40351199 |
| | Elevated sphingomyelinase activity and ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment: implications for endothelial apoptosis | Q40386161 |
| | Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts | Q41075744 |
| | Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma | Q41370077 |
| | Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling | Q42450640 |
| | Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma | Q43528309 |
| | Lung metastasectomy following kidney tumors: outcomes and prognostic factors from a single-center experience. | Q44065163 |
| | Can RENAL and PADUA nephrometry indices predict complications of laparoscopic cryoablation for clinical stage T1 renal tumors? | Q44917582 |
| | The Value of Radiotherapy in the Treatment of Hypernephroma-a Clinical Trial | Q45100876 |
| | A randomized trial of postoperative radiotherapy versus observation in stage II and III renal adenocarcinoma. A study by the Copenhagen Renal Cancer Study Group | Q45171717 |
| | Localised prostate cancer: the PREFERE trial | Q45213454 |
| | Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma | Q45878242 |
| | Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993-2004. | Q45942778 |
| | Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. | Q46035256 |
| | Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney | Q46496654 |
| | Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours | Q46590684 |
| | Preservation of renal function following partial or radical nephrectomy using 24-hour creatinine clearance. | Q46648824 |
| | Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy". | Q47103965 |
| | First Ever Use of Proton Stereotactic Body Radiation Therapy Delivered with Curative Intent to Bilateral Synchronous Primary Renal Cell Carcinomas. | Q47162224 |
| | Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). | Q47269792 |
| | Carbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience | Q47809473 |
| | The radiosensitivity of brain metastases based upon primary histology utilizing a multigene index of tumor radiosensitivity | Q48229143 |
| | Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment? | Q48506272 |
| | External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center | Q48774788 |
| | A phase II trial of sunitinib in patients with renal cell cancer and untreated brain metastases | Q48852932 |
| | Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. | Q48918183 |
| | Abscopal effect in metastatic renal cell carcinoma | Q49168870 |
| | Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases | Q50059401 |
| | Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma. | Q50119482 |
| | Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial. | Q50898681 |
| | Single fraction radiosurgery for the treatment of renal tumors. | Q51054482 |
| | Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma. | Q52093428 |
| | Renal cell carcinoma: a review of biology and pathophysiology. | Q52724797 |
| | Effect of Stereotactic Body Radiotherapy on the Growth Kinetics and Enhancement Pattern of Primary Renal Tumors. | Q52984774 |
| | Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. | Q53271608 |
| | TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II | Q57795895 |
| | Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location | Q58113167 |
| | Updated long-term outcomes after carbon-ion radiotherapy for primary renal cell carcinoma | Q58776063 |
| | Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma | Q61810400 |
| | Proceedings: Carcinoma of the kidney | Q69617597 |
| | Tumor response to radiotherapy regulated by endothelial cell apoptosis | Q73401346 |
| | Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized study | Q73513568 |
| | [Treatment of metastatic renal cell carcinoma. Value of immunotherapy compared with surgery of metastases] | Q74220292 |
| | A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma | Q80282852 |
| | Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors | Q80720665 |
| | Four-dimensional computed tomography scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver | Q80976365 |
| | Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma | Q81091805 |
| | Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma | Q81879762 |
| | Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma | Q83946224 |
| | Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy | Q84100476 |
| | Stereotactic Ablative Radiotherapy (SABR) for Large Renal Tumors: A Retrospective Case Series Evaluating Clinical Outcomes, Toxicity, and Technical Considerations | Q88345776 |
| P304 | page(s) | 104-112 | |
| P577 | publication date | 2019-04-26 | |
| P1433 | published in | Clinical and Translational Radiation Oncology | Q50817416 |
| P1476 | title | Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma? | |
| P478 | volume | 18 | |